| 1 |
33941102 |
10.1186/s12885-021-08142-7 |
2021 |
Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma. |
IL16 |
| 2 |
32735617 |
10.1371/journal.ppat.1008701 |
2020 |
Interleukin 16 contributes to gammaherpesvirus pathogenesis by inhibiting viral reactivation. |
IL16 |
| 3 |
28574850 |
10.18632/oncotarget.17959 |
2017 |
Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients. |
IL16 |
| 4 |
24794807 |
10.3109/10428194.2014.919634 |
2015 |
CCR4+T cell recruitment to the skin in mycosis fungoides: potential contributions by thymic stromal lymphopoietin and interleukin-16. |
IL16 |
| 5 |
23893766 |
10.1002/jcp.24441 |
2014 |
Regulation of cellular processes by interleukin-16 in homeostasis and cancer. |
IL16 |
| 6 |
23297678 |
10.1111/sji.12026 |
2013 |
Pro-IL-16 is associated with MHC class II-mediated negative regulation of mouse resting B cell activation through MAP kinases, NF-κB and Skp2-dependent p27kip regulation. |
IL16 |
| 7 |
20878214 |
10.1007/s10875-010-9464-8 |
2011 |
Interleukin-16 as a marker of Sézary syndrome onset and stage. |
IL16 |
| 8 |
21818556 |
10.1007/s00432-011-1017-x |
2011 |
Introduction of pro-interleukin-16 inhibits T-lymphoblastic leukemia growth in mice. |
IL16 |
| 9 |
22080865 |
10.1172/JCI41769 |
2011 |
Loss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphoma. |
IL16 |
| 10 |
20802378 |
10.1097/FPC.0b013e32833deb16 |
2010 |
A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimens. |
IL16 |
| 11 |
19066394 |
10.1182/blood-2008-04-153858 |
2009 |
Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. |
IL16 |
| 12 |
18633131 |
10.1182/blood-2007-09-111658 |
2008 |
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era. |
IL16 |
| 13 |
17577790 |
10.1080/10428190701268767 |
2007 |
Serum levels of interleukin-16 in lymphoid malignancies. |
IL16 |
| 14 |
16709867 |
10.4049/jimmunol.176.11.7051 |
2006 |
Leukotriene A4 hydrolase expression in PEL cells is regulated at the transcriptional level and leads to increased leukotriene B4 production. |
IL16 |
| 15 |
12769791 |
10.2174/1568005033481178 |
2003 |
Current perspectives on cytokines for anti-retroviral therapy in AIDS related B-cell lymphomas. |
IL16 |
| 16 |
11967309 |
10.1128/jvi.76.10.4919-4927.2002 |
2002 |
Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype. |
IL16 |
| 17 |
11298554 |
10.1046/j.1365-2133.2001.04150.x |
2001 |
Angioimmunoblastic lymphadenopathy-type peripheral T-cell lymphoma with cutaneous infiltration: report of a case and its gene expression profile. |
IL16 |
| 18 |
10692046 |
10.1046/j.1365-2567.2000.00959.x |
2000 |
Human B-cell lines constitutively express and secrete interleukin-16. |
IL16 |
| 19 |
10949545 |
10.1034/j.1600-0625.2000.009004248.x |
2000 |
IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression. |
IL16 |
| 20 |
11064099 |
10.1016/s0165-2478(00)00258-3 |
2000 |
CXCR4 and CCR5 expression by H9 T-cells is downregulated by a peptide-nucleic acid immunomodulator. |
IL16 |
| 21 |
11154979 |
10.1159/000039756 |
2000 |
The cellular immune system of patients with acute leukemia and severe chemotherapy-induced leukopenia: characterization of T lymphocyte subsets responsive to IL-16 and IL-17. |
IL16 |
| 22 |
10504456 |
10.1046/j.1523-1747.1999.00717.x |
1999 |
Expression of the CD4+ cell-specific chemoattractant interleukin-16 in mycosis fungoides. |
IL16 |
| 23 |
3286773 |
|
1988 |
Functional analysis of mononuclear cells infiltrating into tumors. III. Soluble factors involved in the regulation of T lymphocyte infiltration into tumors. |
IL16 |
Datasets
Models
